Soleno Therapeutics, Inc. Accounts Payable for the year ending December 31, 2024: USD 8.88 M

Soleno Therapeutics, Inc. Accounts Payable is USD 8.88 M for the year ending December 31, 2024, a 182.06% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Soleno Therapeutics, Inc. Accounts Payable for the year ending December 31, 2023 was USD 3.15 M.
  • Soleno Therapeutics, Inc. Accounts Payable for the year ending December 31, 2021 was USD 3.25 M.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities